Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting
A recent clinical quandary focused on the diagnosis and treatment of blastic plasmacytoid dendritic cell neoplasm in a resource-limited setting.
A recent clinical quandary focused on the diagnosis and treatment of blastic plasmacytoid dendritic cell neoplasm in a resource-limited setting.
Data from the phase 3 CRC-PREVENT trial support the sensitivity of ColoSense in the detection of colorectal cancer.
Diepstraten et al. demonstrate that p53 enforces apoptosis induced by BH3-mimetic drugs. To boost BH3-mimetic-induced apoptosis in TP53-mutant blood cancers, STING agonists were employed to induce…
The annual Champions for Change Gala is The Skin Cancer Foundation’s signature fundraising event. Funds raised from the Gala support the Foundation’s lifesaving educational campaigns,…
ACS’ standardized training & credentialing program for professional patient navigators is designed to help health systems in delivering essential support to people with cancer. Learn…
Minoo Battiwalla, MD, discusses recent advancements in the multiple myeloma treatment paradigm.
Cancer Research | 84 | 10 | May 2024
First-line atezolizumab plus sacituzumab govitecan led to responses in PD-L1–positive locally advanced or metastatic triple-negative breast cancer.
One of the first HPV self-collection solutions has been approved by the FDA, which can identify women at risk of developing cervical cancer.
The CT Screening Symposium is a 1-day, immersive, in-person event being featured at WCLC 2024 focused on lung cancer screening technologies and best practices. …
Lillian L. Siu discovered her passion while perusing employment ads in the Journal of Clinical Oncology. “I literally opened JCO, the Journal of Clinical Oncology,…